Avatar
Europeeight8

0 Following 0 Followers
1
Ients with advanced ovarian carcinoma? Am J Obstet Gynecol. 2014;211(3):231. e231?39. 3. Martin LP, Sill M, Shahin MS, Powell M, DiSilvestro P, Landrum LM, et al. A phase II evaluation of AMG 102 (rilotumumab) in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal carcinoma: a Gynecologic Oncology Group study. Gynecol Oncol. 2014;132(3):526?0. 4. Matsu
1
As remain controversial, and the present long-term follow-up retrospective study reveals that high ALDH1 expression in tumor cells portends favorable prognosis and better survivals in patients with ovarian carcinoma, but the expression of ALDH1 in stromal cells has no associations with clinical outcomes. More studies are warranted to verify the potential role of ALDH1 in ovarian carcinoma progress
1
As remain controversial, and the present long-term follow-up retrospective study reveals that high ALDH1 expression in tumor cells portends favorable prognosis and better survivals in patients with ovarian carcinoma, but the expression of ALDH1 in stromal cells has no associations with clinical outcomes. More studies are warranted to verify the potential role of ALDH1 in ovarian carcinoma progress
1
As remain controversial, and the present long-term follow-up retrospective study reveals that high ALDH1 expression in tumor cells portends favorable prognosis and better survivals in patients with ovarian carcinoma, but the expression of ALDH1 in stromal cells has no associations with clinical outcomes. More studies are warranted to verify the potential role of ALDH1 in ovarian carcinoma progress
1
He University of Texas MD Anderson Cancer Center. In their long-term follow-up study, The same mouse monoclonal anti-human ALDH Clone 44 from BD Transduction LaboratoriesTM was used, and it turned out that high level of ALDH1 was detected in 19 out of the total 442 ovarian carcinoma samples, and it was significantly associated with endometrioid adenocarcinoma, early-stage tumor, complete respons
1
Tion, and return home healthy.John D Grabenstein deputy director Military Vaccine Agency, 5113 Leesburg Pike, Suite 402, Falls Church, VA 22041 USA john.grabenstein@us.army.mil William Winkenwerder Jr assistant secretary of defense (health affairs) Washington, DC, USA5 Eckart RE, Love SS, Atwood JE, Arness MK, Cassimatis DC, Campbell CL, et al. Incidence and follow-up of inflammatory cardiac compl
1
Ulates retinoic acid signalling in mediating islet differentiation and survival. Diabetologia. 2014;57(4):754?4. 6. Huang EH, Hynes MJ, Zhang T, Ginestier C, Dontu G, Appelman H, et al. Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis. Cancer Res. 2009;69(8):3382?. 7. Moreb JS, Baker HV, Chang LJ, Am
1
E data: CGT. Wrote the manuscript: RHuang, XL, RHolm, JMN, CGT, ZS. All authors read and approved the final manuscript. All authors read and approved the final manuscript. Acknowledgments This study was financially supported by grants from Inger and John Fredriksen Foundation and Radium Hospital Research Foundation and The Norwegian Cancer Society. We thank Ellen Hellesylt, Mette Synn e F sund, Ma